Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TFI | 44.13 | 0.16 | +0.36% |
| State Street SPDR Nuveen ICE Municipal Bond ETF (TFI) | |||
| SPVM | 77.75 | 0.14 | +0.18% |
| Invesco S&P 500 Value with Momentum ETF (SPVM) | |||
| FCBD | 24.91 | 0.04 | +0.16% |
| Frontier Asset Core Bond ETF | |||
| TINS | 28.04 | N/A | N/A |
| Templeton International Insights ETF (TINS) | |||
| DMAR | 45.76 | -0.21 | -0.45% |
| FT Vest US Equity Deep Buffer ETF - March (DMAR) | |||
| Ticker / NAME | Correlation To FRNM | 1D Price Change % |
|---|---|---|
| FRNM | 100% | -2.95% |
| Medical Specialties category (43 stocks) | 5% Poorly correlated | -3.31% |
| Medical Specialties category (43 stocks) | 5% Poorly correlated | -3.31% |
Industry MedicalSpecialties